Osteal Therapeutics

Funding and NIH signals

• SEC Form D raise Raised $15.6M (Form D filed Nov 5, 2025). SEC Form D 0001231919-25-000432 (Nov 5, 2025)
  Evidence (1 event)

  • Nov 5, 2025 · SEC Form D 0001231919-25-000432
    Name of Issuer: Osteal Therapeutics, Inc.; CIK: 1735936; Address: Dallas, TX; Submission type: D; Filing date: 2025-11-05; Industry Group: Pharmaceuticals; Date of First Sale: 2025-10-17; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 26702156; Total Amount Sold: 15602151; Federal exemptions: 06b

Job counts as of Oct 18, 2026. All funding and NIH signals

Raises and deals from press releases

• Raise Series D · $50M · announced Jun 5, 2024 Company release ↗
  Source quote

  • Jun 5, 2024 · Company release ↗
    “Osteal Therapeutics Closes $50M Series D Financing to Support Approval and Commercial Launch of Lead Candidate Financing led by Zimmer Biomet with participation from existing investors Johnson & Johnson Innovation – JJDC, Inc., Gideon Strategic Partners, and HM Capital.”

Raises announced in these releases: $50M disclosed.

From the company’s own releases; this list is partial. All raises and deals